Outsourcing Pharma
JANUARY 9, 2024
Medable Inc. has announced a new intelligent automation technology applied across its clinical trials platform it hopes will cut standard trial build timelines by at least half.
Bio Pharma Dive
JANUARY 9, 2024
Albert Bourla acknowledged Pfizer’s difficult 2023, while a biotech CEO spoke with BioPharma Dive about building neuroscience startups.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
AuroBlog - Aurous Healthcare Clinical Trials blog
JANUARY 9, 2024
It seems the time that wounds take to heal is partly down to mentality: researchers have found that healing happens faster when the person involved thinks that time is progressing more quickly than it actually is.
Rethinking Clinical Trials
JANUARY 9, 2024
Speaker Speaker: Rui Wang, PhD Associate Professor of Population Medicine and Associate Professor in the Department of Biostatistics, Harvard Pilgrim Health Care Institute and Harvard Medical School Moderator: Fan Li, PhD Assistant Professor of Biostatistics, Yale School of Public Health Slides Keywords Cluster-randomized; Intervention; Missingness; Outcomes Key Points Cluster randomized trials are trials in which clusters of individuals rather than independent individuals ar
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Bio Pharma Dive
JANUARY 9, 2024
Aiolos, which raised a Series A round three months ago, is developing an antibody that shares a target with Amgen and AstraZeneca’s Tezspire.
AuroBlog - Aurous Healthcare Clinical Trials blog
JANUARY 9, 2024
Experts in the life-sciences industry are of the view that doing away with human studies for new drugs in India is unscientific and risky as patients here have different anthropometry.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Pharmaceutical Technology
JANUARY 9, 2024
BIOS Health has partnered with the City of Bakersfield, Kern County, and Kern Venture Group to set up a precision medicine centre in the US.
Fierce Pharma
JANUARY 9, 2024
Pfizer knows it had a bad year in 2023. Speaking to reporters at the 2024 J.P. | Pfizer knows it had a bad year in 2023. Speaking to reporters at the 2024 J.P. Morgan Healthcare Conference on Monday, the company’s CEO, Albert Bourla, spoke bluntly about the hits the company took, and he acknowledged the underperformance of certain key launches.
Pharmaceutical Technology
JANUARY 9, 2024
dispenSense, part of Navi Group, is a Category Award Winner in three areas in the 2023 Pharmaceutical Technology Excellence Awards
pharmaphorum
JANUARY 9, 2024
Discover how the UK Biobank is leveraging technology and the power of genomics in data-driven disease research. Join the digital revolution in understanding and combating diseases using cutting-edge techniques and large-scale genomic data analysis.
Pharmaceutical Technology
JANUARY 9, 2024
The proceeds from the private placement will fund the development of Zealand’s obesity pipeline, including two Phase II candidates.
CTTI (Clinical Trials Transformation Initiative)
JANUARY 9, 2024
Today, the U.S. Food and Drug Administration (FDA) and the Clinical Trials Transformation Initiative (CTTI) announced eight newly selected representatives for the Patient Engagement Collaborative (PEC). The group of 16 patients, caregivers, and patient group representatives meets with the FDA several times a year and discusses a variety of topics such as improving communication, education, and patient engagement related to medical product regulation.
Pharmaceutical Technology
JANUARY 9, 2024
Approval for zolbetuximab was quashed after the FDA found deficiencies in the company’s third-party manufacturing.
Pharma Times
JANUARY 9, 2024
The fertilised eggs could cultivate tumours for imaging within seven days
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Pharmaceutical Technology
JANUARY 9, 2024
Biocytogen Pharmaceuticals and Radiance Biopharma have signed an exclusive option and licence agreement for a BsADC.
Pharma Times
JANUARY 9, 2024
Both aim to advance the use of AI-powered cell analysis for cancer, stem cell and cell therapies
Pharmaceutical Technology
JANUARY 9, 2024
Set to lose Keytuda patent protection in 2028, MSD is shoring up its oncology portfolio with immunotherapies.
pharmaphorum
JANUARY 9, 2024
In a new episode of the pharmaphorum podcast, host Nicole Raleigh speaks with Aman Wasan, CEO of ArisGlobal, about the digitisation of drug research and development, including using automation to analyse large datasets to identify new drug development opportunities, with patient safety ever at the forefront of such innovations.
Pharmaceutical Technology
JANUARY 9, 2024
Johnson & Johnson (J&J) has signed a definitive agreement for the acquisition of Ambrx Biopharma in a cash deal valued at $2bn.
Fierce Pharma
JANUARY 9, 2024
Two successful phase 3 trials put Astellas’ monoclonal antibody zolbetuximab on track to become the first approved therapy to treat one of the hottest targets in oncology—tumors that are claudin (C | Two successful phase 3 trials put Astellas’ monoclonal antibody zolbetuximab on track to become the first approved therapy to treat one of the hottest targets in oncology—tumors that are claudin (CLDN) positive.
Pharmaceutical Technology
JANUARY 9, 2024
The EC has granted approval for Pfizer’s Talzenna (talazoparib) to treat adults with metastatic castration-resistant prostate cancer (mCRPC).
pharmaphorum
JANUARY 9, 2024
Manufacturing problems have scuppered Astellas’ chances of approval in the US this month for zolbetuximab, currently leading the field among Claudin 18.2-targeted drug candidates for cancer.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Drug Patent Watch
JANUARY 9, 2024
A recent story by NPR echoes the findings of a collaboration between DrugPatentWatch and Bloomberg, which examined increasing competition between generic drug makers. The NPR article discusses the challenges in… The post NPR on how low Drug Prices can Shortages appeared first on DrugPatentWatch - Make Better Decisions.
pharmaphorum
JANUARY 9, 2024
Amazon has launched an initiative with Omada Health at JPM that makes it easier for patients to discover and enrol in digital health benefit programmes
Pharmaceutical Commerce
JANUARY 9, 2024
Review article explores the latest developments surrounding expression and purification strategies.
pharmaphorum
JANUARY 9, 2024
JPM: GSK announces $1.4bn deal to buy asthma biotech Aiolos Phil.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
XTalks
JANUARY 9, 2024
Thyroid Awareness Month is marked every January to emphasize the importance of thyroid health. The theme of Thyroid Awareness Month 2024 is “Nurturing Thyroid Health: Knowledge, Detection and Wellness.” The month focuses on understanding the thyroid’s vital role in many bodily functions, encouraging testing and early treatment for thyroid dysfunctions and advocating for awareness about the different types of thyroid diseases.
pharmaphorum
JANUARY 9, 2024
Discover how AI innovations are revolutionising the engagement between life sciences companies and healthcare professionals. Learn about the latest advancements and their impact on the industry.
Fierce Pharma
JANUARY 9, 2024
After Roche went through a period of declining sales in hematology—as powerhouse Rituxan faced biosimilar competition and follow-on Gazyva failed to live up to its blockbuster expectations—the comp | After Roche went through a period of declining sales in hematology—as powerhouse Rituxan faced biosimilar competition and follow-on Gazyva failed to live up to its blockbuster expectations—the company is rebounding quickly in blood cancer.
pharmaphorum
JANUARY 9, 2024
Novo Nordisk Foundation has put $25m of funding into CARB-X, an initiative that aims to tackle antimicrobial resistance (AMR).
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Expert insights. Personalized for you.
102 
Let's personalize your content